COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® Reports Fourth Quarter and Full Year 2018 Financial and Operating Results

25/02/2019 - 22:05

- Completes eptinezumab’s Biologics License Application (BLA) submission - - Remains on track for eptinezumab’s commercial launch in Q1-2020 - - Strengthens leadership team with the appointments of Carlos Campoy as [...]

Medexus Pharmaceuticals Announces 512% Increase in Revenue to $14.4 Million for the Third Quarter of Fiscal 2019

25/02/2019 - 22:05

Generates $2.2 million of Adjusted EBITDA Medexus management to host conference call at 4:30 PM ET today MONTREAL, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company [...]

Stryker acquires Arrinex

25/02/2019 - 22:05

Kalamazoo, Michigan, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has [...]

La Jolla Pharmaceutical Company to Release Fourth Quarter and Full Year 2018 Financial Results on March 4, 2019

25/02/2019 - 22:04

SAN DIEGO, Feb. 25, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

VistaGen Therapeutics Announces Proposed Public Offering of Common Stock

25/02/2019 - 22:03

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central [...]

Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership Changes

25/02/2019 - 22:01

Preparation for Resubmission of BLA for Sacituzumab Govitecan Continuing Phase 2 Data in mTNBC Published in New England Journal of Medicine Oral Presentation of Updated Phase 1/2 Results with Sacituzumab Govitecan in [...]

Ultragenyx Announces Proposed Public Offering of Common Stock

25/02/2019 - 22:01

NOVATO, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, [...]

HealthPoint Plus, Inc. Announces Plan to File S-1 Registration Statement with the SEC to Register its Securities for Public Trading

25/02/2019 - 20:19

Danvers, MA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- HealthPoint Plus, Inc. www.healthpointplus.com announced today that it plans to file an S-1 registration statement upon completion of its final round of [...]

B. Braun Medical Acquires NxStage Medical, Inc.’s Streamline Bloodlines

25/02/2019 - 19:54

BETHLEHEM, Pa., Feb. 25, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. is pleased to announce the acquisition of the Medisystems ® Streamline ® Bloodlines business. The acquired bloodline systems will include the [...]

CORRECTION – Exactus Announces Inaugural Product Launch

25/02/2019 - 19:18

First Customer Sale Kicks Off Commercial Operations GLEN ALLEN, Va., Feb. 25, 2019 (GLOBE NEWSWIRE) -- This release corrects and replaces the version issued this morning at 6:30 AM ET. The complete and corrected release [...]

Sanofi: Positive results presented from two Phase 3 trials of Dupixent® (dupilumab) in severe chronic rhinosinusitis with nasal polyps

25/02/2019 - 18:46

Press Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY) Positive results presented from two Phase 3 trials of Dupixent ® (dupilumab) in severe chronic rhinosinusitis with nasal polyps Dupixent showed significant [...]

Sanofi : Présentation des résultats positifs de deux essais de phase III du Dupixent® (dupilumab) dans le traitement de la polypose nasosinusienne sévère

25/02/2019 - 18:46

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NASDAQ : SNY) Présentation des résultats positifs de deux essais de phase III du Dupixent ® (dupilumab) dans le traitement de la polypose nasosinusienne sévère [...]

Urology Associates of Nashville Offers HIFU Treatment for Localized Prostate Cancer

25/02/2019 - 18:14

HIFU, or High Intensity Focused Ultrasound, is a minimally invasive, outpatient treatment for prostate cancer CHARLOTTE, N.C., Feb. 25, 2019 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC, the leading provider of HIFU [...]

RUDDCO Inc. retracts announcement concerning the Operations in the Cranbrook Garden

25/02/2019 - 18:02

MIAMI, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Ruddco Inc., a Florida based company, announced in a previous press release dated December 20, 2018 the opening of activities in the Cranbrook Botanical Gardens by its joint [...]

Genmab Announces Positive Topline Results in Phase III COLUMBA Study of Subcutaneous Daratumumab

25/02/2019 - 17:47

Company Announcement Phase III COLUMBA study comparing the subcutaneous formulation of daratumumab to the intravenous formulation in patients with relapsed or refractory multiple myeloma met both co-primary endpoints [...]

Acacia Pharma to Announce Its Results For the Full Year 2018 on Wednesday 27 February

25/02/2019 - 17:14

Cambridge, UK and Indianapolis, US – 25 February 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH), a hospital pharmaceutical company focused on the development and commercialisation of new [...]

Ossur Hf : Transactions in relation to share buyback program

25/02/2019 - 17:01

Announcement no. 13/2019 22 February 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Oncology Startup Notable Expands Leadership Team With New Chief Medical and Chief Development Officers

25/02/2019 - 17:00

Former Incyte, Aquinox executives bring decades of experience in cancer drug development FOSTER CITY, Calif., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Notable , which is redefining cancer treatment with a clinically validated [...]

Rafina Innovations Develops a Prototype Named Flexi Cuff for Deep Vein Thrombosis Patients

25/02/2019 - 16:30

GLASGOW, SCOTLAND, Feb. 25, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Rafina Innovations Inc. ("the Company" (OTCQB: VICA)) is pleased to announce that it has developed a product prototype to assist patients with [...]